ImmuCell Corporation Stock News

PORTLAND, Maine, Feb. 18, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets.

Biotech stocks were quiet in the week ending Feb. 14 amid some data readouts at a couple of conferences and earnings news flow from smid-cap companies. The following are key biotech catalysts to look

ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that im

News like the Coronavirus can affect the stock market — either as a whole or just certain stocks and sectors. See how you can prepare.

January is turning out to be a bit of a roller-coaster market for my main account. The last trade I took in the account on Wednesday in Neurotrope, Inc. (NASDAQ: NTRP) ended up netting me another $16

Investors can approximate the average market return by buying an index fund. While individual stocks can be big...

ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that im

Q3 2019 ImmuCell Corp Earnings Call

Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts, usually don't make them change their opinion towards

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...